Yes. HIV spreads through blood, so sharing needles, syringes, or any drug-injection equipment is one of the most efficient ways the virus moves between people. When you reuse a needle someone else has used, infected blood left inside it can enter your bloodstream directly. This route is highly preventable with clean equipment, PrEP, and testing.
flu-like; many have none
when undetectable
| Item | Value |
|---|---|
| Acute symptoms | 2–4 wks — flu-like; many have none |
| NAT detects | 10–33 days |
| Antibody test | 23–90 days |
| U=U | no transmission — when undetectable |
How HIV is actually transmitted
HIV is a virus that attacks the immune system, and it only travels in certain body fluids: blood, semen, vaginal fluid, rectal fluid, and breast milk CDC, About HIV. For an infection to happen, enough virus from one of those fluids has to reach the bloodstream through a needle, a mucous membrane, or broken skin. Sweat, tears, and casual touch don't carry it.
Sharing needles and injection equipment
When someone injects, a small amount of blood draws back into the syringe. If you then use that same needle, syringe, cooker, cotton, or rinse water, that blood and any HIV in it goes straight into your vein CDC, How HIV Spreads. Because it bypasses skin and mucous membranes entirely and lands directly in the bloodstream, the per-event risk from a shared needle is among the highest of any route. The spoon or cooker, the filter, and the water used to rinse can all carry infected blood between people too.
Sexual transmission
HIV also spreads through anal or vaginal sex when semen, vaginal fluid, or rectal fluid contacts the mucous membranes that line those tissues. Receptive anal sex carries the highest sexual risk because the rectal lining is thin and easily injured. People who inject drugs often have sex partners too, so injection and sexual transmission frequently overlap in the same networks.
From parent to baby (perinatal)
HIV can pass during pregnancy, delivery, or breastfeeding. This route is now largely preventable: with HIV treatment during pregnancy and labor plus medicine for the newborn, the chance of passing HIV to the baby can drop to less than one percent.
How HIV is NOT transmitted
HIV doesn't survive long outside the body, so the everyday contact people worry about doesn't spread it. You cannot get HIV from any of the following:
- Toilet seats, doorknobs, or other surfaces — the virus dies quickly in the open air.
- Sharing towels, dishes, cups, or food.
- Hugging, shaking hands, or other casual contact with someone who has HIV.
- Saliva, tears, or sweat — kissing alone does not transmit HIV.
- Mosquito or insect bites — HIV doesn't replicate in insects.
- Drinking water, swimming pools, or air.
- Donating blood — sterile, single-use equipment is used every time.
For people who use drugs, the risk lies in the shared blood inside the equipment. Being around someone who uses carries none of it. Using your own clean, never-shared works removes the blood-borne route entirely.
Who's at higher risk
About 38,800 people were newly diagnosed with HIV in the US in 2023, and roughly 1.12 million are living with it; about two-thirds are virally suppressed on treatment CDC AtlasPlus, 2023. People who inject drugs are a core risk group because shared equipment moves the virus so efficiently. The burden also clusters geographically, with diagnosis rates highest in Washington DC and across the South, including Georgia, Florida, and Louisiana.
Within injection drug use, a few factors raise risk further: injecting more frequently, sharing with more people, reusing cookers and cotton, and combining injection with condomless sex. If any of that describes your situation, regular testing and prevention tools matter more, not less.
Reducing the risk
For injection drug use, the most direct protection is never sharing. Use a new, sterile needle and syringe for every injection, and don't share cookers, cotton, or rinse water. Many communities have syringe services programs that provide clean supplies and safe disposal. The CDC's core prevention toolkit applies here too: PrEP, PEP, treatment-as-prevention, and regular testing.
PrEP — pre-exposure prophylaxis — is medicine you take before exposure to keep HIV from taking hold. It's approved for people at risk through injection drug use as well as sex. Daily oral truvada - a pill that may prevent hiv infection (emtricitabine/tenofovir disoproxil fumarate) is the option approved for the injection route. Taken as prescribed, PrEP lowers HIV risk from injection drug use by at least 74 percent, and from sex by about 99 percent CDC, PrEP. Descovy is not approved for people who inject drugs, so Truvada is the right choice for this route. PrEP requires a confirmed HIV-negative test before you start and regular follow-up visits.
For partners, treatment-as-prevention works the other way: a person with HIV who takes their medicine and stays undetectable does not transmit the virus to sex partners. That's U=U, undetectable equals untransmittable. Across the PARTNER studies, mixed-status couples had more than a hundred thousand condomless sex acts and recorded zero linked transmissions while the positive partner was virally suppressed Lancet, PARTNER. Most people reach undetectable within about six months of starting treatment CDC, U=U.
Here's how the main prevention tools compare:
| Tool | What it is | Who it's for | How well it works |
|---|---|---|---|
| Clean needles / works | New sterile equipment, never shared | Anyone who injects | Removes the blood-borne injection route |
| PrEP (Truvada) | Daily pill taken before exposure | People at risk via injection or sex | ≥74% from injection; ~99% from sex when taken as prescribed |
| PEP | 28-day emergency course after exposure | After a possible exposure, within 72 hours | ~81% reduction in seroconversion in the original study |
| Treatment as prevention (U=U) | HIV meds keeping viral load undetectable | People living with HIV | Zero transmission to sex partners while suppressed |
If you may have been exposed
If you shared a needle or had another possible exposure in the last three days, this is a same-day emergency. PEP — post-exposure prophylaxis — is a 28-day course of HIV medicine that must start within 72 hours of exposure; the sooner the better, ideally within hours CDC, PEP. Go to an urgent care or ER and ask for it by name. After that window, you move to testing — see when to test after exposure for the timing, and learn about the options under hiv testing.
When to see a clinician
The USPSTF gives HIV screening a Grade A recommendation: everyone ages 15 to 65 should be tested at least once, and people at increased risk — including anyone who injects drugs — should test at least annually USPSTF, Grade A. See a clinician promptly if you've shared injection equipment, want to start PrEP, or develop flu-like symptoms a couple of weeks after a possible exposure. About 9 in 10 people get fever, sore throat, or body aches two to four weeks after infection, which is when the virus level peaks and you're most contagious, so symptoms after a risk warrant an urgent test StatPearls. You can get tested whenever you have a concern; you don't need symptoms to justify it.